1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D9BAEC6AFC210CE885256D3400003942
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/communicating-clinical-trial-results-to-physicians?opendocument
18
19opendocument
2044.222.131.239
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Clinical Operations » Communicating Clinical Trial Results

Communicating Clinical Trial Results to Physicians

DB Image

ID: 4430


Features:

Metrics, Graphics


Words: 7,000


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 20-page document includes best practices and supporting graphics for communicating clinical trial results to key opinion leaders and future prescribing physicians. Physicians represent the largest and most influential audience for clinical trial results. Therefore, companies concentrate the majority of their resources and efforts on effectively reaching this group. The document reviews the relative importance of communications channels and outlines tactics to initiate a cascade of influence with a hierarchy of Key Opinion Leaders and how to measure the memorability of key clinical trial messages among physicians, among several other practices. This research originated from Best Practices, LLC's consulting services.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Abbott Laboratories; Sanofi-aventis; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; GlaxoSmithKline; Janssen; Merck; Pharmacia; Novartis; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.